Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research ArticleClinical Studies

Factors Related to Overactive Bladder-like Symptoms in Bladder Cancer

MASAHIRO TACHIBANA, KAZUNA TSUBOUCHI, YUICHIRO FUKUHARA, CHIKAO AOYAGI, KOSUKE TOMINAGA, NAOTAKA GUNGE, YU OKABE, TAKESHI MIYAZAKI, TAIKI EMOTO, CHIZURU NAKAGAWA, FUMIHIRO YAMAZAKI, HIROSHI MATSUZAKI, NOBUYUKI NAKAMURA and NOBUHIRO HAGA
Anticancer Research August 2023, 43 (8) 3607-3613; DOI: https://doi.org/10.21873/anticanres.16540
MASAHIRO TACHIBANA
Department of Urology, Fukuoka University Faculty of Medicine, Fukuoka, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
KAZUNA TSUBOUCHI
Department of Urology, Fukuoka University Faculty of Medicine, Fukuoka, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
YUICHIRO FUKUHARA
Department of Urology, Fukuoka University Faculty of Medicine, Fukuoka, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
CHIKAO AOYAGI
Department of Urology, Fukuoka University Faculty of Medicine, Fukuoka, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
KOSUKE TOMINAGA
Department of Urology, Fukuoka University Faculty of Medicine, Fukuoka, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
NAOTAKA GUNGE
Department of Urology, Fukuoka University Faculty of Medicine, Fukuoka, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
YU OKABE
Department of Urology, Fukuoka University Faculty of Medicine, Fukuoka, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
TAKESHI MIYAZAKI
Department of Urology, Fukuoka University Faculty of Medicine, Fukuoka, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
TAIKI EMOTO
Department of Urology, Fukuoka University Faculty of Medicine, Fukuoka, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
CHIZURU NAKAGAWA
Department of Urology, Fukuoka University Faculty of Medicine, Fukuoka, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
FUMIHIRO YAMAZAKI
Department of Urology, Fukuoka University Faculty of Medicine, Fukuoka, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
HIROSHI MATSUZAKI
Department of Urology, Fukuoka University Faculty of Medicine, Fukuoka, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
NOBUYUKI NAKAMURA
Department of Urology, Fukuoka University Faculty of Medicine, Fukuoka, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
NOBUHIRO HAGA
Department of Urology, Fukuoka University Faculty of Medicine, Fukuoka, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: nhaga@fukuoka-u.ac.jp
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

Background/Aim: The aim of the present study was to investigate the factors related to overactive bladder (OAB)-like symptoms in patients with bladder cancer. Patients and Methods: This study included 59 patients who underwent transurethral resection of bladder tumor (TURBT). OAB-like symptoms were identified based on the Overactive Bladder Symptom Score (OABSS) and International Prostate Symptom Score (IPSS) questionnaires. The main outcome measures were elucidation of bladder cancer-related factors that might induce OAB-like symptoms. Results: Non-muscle invasive bladder cancer (NMIBC) was observed in 50 patients, and carcinoma in situ (CIS) was observed in 14 patients. OABSS total score, IPSS total score, and quality of life index were 5±3, 12±7 and 3±1, respectively. The OABSS question 1 score, indicating pollakisuria, was significantly higher in NMIBC patients with CIS than in those without CIS (presence of CIS vs. absence of CIS=1.0±0.6 : 0.5±0.6, p=0.02). IPSS question 4 score, indicating urgency (r=0.31, p=0.01), and OABSS question 4 score, indicating urgency incontinence (r=0.29, p=0.03), correlated significantly with the maximum bladder tumor diameter. Multivariate regression analysis demonstrated that presence of CIS in NMIBC cases correlated significantly with pollakisuria (p=0.02), and that maximum diameter of the bladder tumor correlated significantly with both urgency (p=0.04) and urgency incontinence (p=0.01). Conclusion: CIS induced pollakisuria in NMIBC. Larger diameter bladder tumors induced both urgency and urgency incontinence. Patients with bladder cancer who present with pollakisuria might have CIS.

Key Words:
  • Bladder cancer
  • overactive bladder
  • non-muscle invasive
  • carcinoma in situ
  • Received May 18, 2023.
  • Revision received June 15, 2023.
  • Accepted June 19, 2023.
  • Copyright © 2023 International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.
View Full Text

This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.

patientACCESS

patientACCESS - Patients desiring access to articles
PreviousNext
Back to top

In this issue

Anticancer Research: 43 (8)
Anticancer Research
Vol. 43, Issue 8
August 2023
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Factors Related to Overactive Bladder-like Symptoms in Bladder Cancer
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
1 + 0 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Factors Related to Overactive Bladder-like Symptoms in Bladder Cancer
MASAHIRO TACHIBANA, KAZUNA TSUBOUCHI, YUICHIRO FUKUHARA, CHIKAO AOYAGI, KOSUKE TOMINAGA, NAOTAKA GUNGE, YU OKABE, TAKESHI MIYAZAKI, TAIKI EMOTO, CHIZURU NAKAGAWA, FUMIHIRO YAMAZAKI, HIROSHI MATSUZAKI, NOBUYUKI NAKAMURA, NOBUHIRO HAGA
Anticancer Research Aug 2023, 43 (8) 3607-3613; DOI: 10.21873/anticanres.16540

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Factors Related to Overactive Bladder-like Symptoms in Bladder Cancer
MASAHIRO TACHIBANA, KAZUNA TSUBOUCHI, YUICHIRO FUKUHARA, CHIKAO AOYAGI, KOSUKE TOMINAGA, NAOTAKA GUNGE, YU OKABE, TAKESHI MIYAZAKI, TAIKI EMOTO, CHIZURU NAKAGAWA, FUMIHIRO YAMAZAKI, HIROSHI MATSUZAKI, NOBUYUKI NAKAMURA, NOBUHIRO HAGA
Anticancer Research Aug 2023, 43 (8) 3607-3613; DOI: 10.21873/anticanres.16540
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Patients and Methods
    • Results
    • Discussion
    • Conclusion
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Comparison of BRCA2 Single Nucleotide Variants Between Japanese Patients With Familial Prostate Cancer, Sporadic Prostate Cancer, and Benign Prostatic Hyperplasia
  • Corrigendum
  • Sex-related Survival Differences in Patients With Glioblastoma – Results From a Retrospective Analysis
Show more Clinical Studies

Similar Articles

Keywords

  • bladder cancer
  • overactive bladder
  • non-muscle invasive
  • carcinoma in situ
Anticancer Research

© 2025 Anticancer Research

Powered by HighWire